LP-199 Medications given to patients with incomplete systemic lupus erythematosus

LP-199 Medications given to patients with incomplete systemic lupus erythematosus

Bibliographic Details
Main Authors:	Anastasiia Shumilova, Yulia Gorbunova, Tatiana Popkova, Tatiana Panafidina, Liubov Kondrateva, Alexandr Lila
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-07-01
Series:	Lupus Science and Medicine

Similar Items

LP-048 Characteristics and clinical outcome of incomplete systemic lupus erythematosus
by: Anastasiia Shumilova, et al.
Published: (2023-07-01)

LP-026 Obesity, hyperleptinemia and insulin resistance in women with systemic lupus erythematosus and rheumatoid arthritis
by: Yulia Gorbunova, et al.
Published: (2023-07-01)

LP-027 Overweight and obesity phenotypes based on body mass index and insulin resistance in women with systemic lupus erythematosus
by: Yulia Gorbunova, et al.
Published: (2023-07-01)

LP-126 The infectious complication in multitarget therapy of class V lupus nephritis: a case report
by: Anastasiia Shumilova, et al.
Published: (2023-07-01)

PO.2.48 Incomplete systemic lupus erythematosus: clinical and immunological manifestations
by: E Nasonov, et al.
Published: (2022-10-01)

LP-203 The new markers of systemic lupus erythematosus activity: focus on interleukin (IL)-1b and soluble IL-2 receptor
by: Mariia Aristova, et al.
Published: (2023-07-01)

LP-113 Systemic lupus erythematosus induced by experimental therapy with a combination of monoclonal antibodies against the sars-cov2 surface s-protein
by: Mariia Aristova, et al.
Published: (2023-07-01)

PO.3.65 The leptin and adiponectin levels in patients with systemic lupus erythematosus and their relationship with cardiovascular risk factors
by: T Panafidina, et al.
Published: (2022-10-01)

LP-095 Macrophage activation in untreated patients with systemic lupus erythematosus (PRELIMINARY DATA)
by: Elena Gerasimova, et al.
Published: (2023-07-01)

PO.4.85 What are the sex differences in patients with systemic lupus erythematosus?
by: T Panafidina, et al.
Published: (2022-10-01)

Clinical significance of leptin in systemic lupus erythematosus
by: L. V. Kondratyeva, et al.
Published: (2021-12-01)

PO.8.170 Drug-induced lupus or systemic lupus erythematosus after experimental COVID-19 therapy: difficulties in differential diagnosis
by: M Aristova, et al.
Published: (2022-10-01)

HEART FAILURE IN SYSTEMIC LUPUS ERYTHEMATOSUS: RISK FACTORS AND DIAGNOSTIC FEATURES
by: T. A. Panafidina, et al.
Published: (2018-07-01)

LP-210 Peripheral blood b-cell subsets in patients with systemic lupus erythematosus
by: Evgeniy Nasonov, et al.
Published: (2023-07-01)

Problems of early diagnosis of systemic lupus erythematosus during the COVID-19 pandemic
by: E. L. Nasonov, et al.
Published: (2021-05-01)

Obesity and overweight phenotypes in patients with systemic lupus erythematosus based on body mass index and serum leptin levels: a pilot cross-sectional study
by: L. V. Kondratyeva, et al.
Published: (2022-07-01)

Genetic load in incomplete lupus erythematosus
by: Joseph M Kheir, et al.
Published: (2023-01-01)

LP-029 Pediatric lupus erythematosus-an interdisciplinary challenge
by: Rodica Olteanu, et al.
Published: (2023-07-01)

Monitoring patients with systemic lupus erythematosus: general characteristics and discussion questions (according to the Canadian Rheumatology Association recommendations)
by: T. A. Panafidina, et al.
Published: (2019-07-01)

LP-204 Chilblain lupus erythematosus-a rare encounter
by: Mohamed Shafi Mahboob Ali
Published: (2023-07-01)

According to the 2019 updated European League Against Rheumatism (EULAR) recommendations for the treatment of systemic lupus erythematosus: debatable issues and comments
by: T. V. Popkova, et al.
Published: (2019-11-01)

LP-070 Medication compliance in systemic lupus erythematosus: community-based study in Surakarta, Indonesia
by: Arief Nurudhin, et al.
Published: (2023-07-01)

LP-162 Prognostic factors for the chronic thrombocytopenia in systemic lupus erythematosus
by: Ji Seon Oh, et al.
Published: (2023-07-01)

LP-185 Treatment of cutaneous lupus erythematosus with energy based devices
by: Jeong Eun Kim, et al.
Published: (2023-07-01)

LP-119 Thalassemia traits in systemic lupus erythematosus patients with anemia
by: Laniyati Hamijoyo, et al.
Published: (2023-07-01)

Systemic lupus erythematosus and antiphospholipid syndrome: past, present, future
by: Evgeny L. Nasonov, et al.
Published: (2023-07-01)

LP-001 Antiphospholipid syndrome in juvenile systemic lupus erythematosus: the Malaysian experience
by: La Reina Sangaran, et al.
Published: (2023-07-01)

Interleukin-18 in systemic lupus erythematosus: link with clinical symptoms and vascular atherosclerosis
by: T A Panafidina, et al.
Published: (2008-05-01)

CLINICAL VALUE OF BAFF AND APRIL CONCENTRATIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS
by: T. A. Panafidina, et al.
Published: (2016-07-01)

Bioimpedance analysis in determining body composition in women with systemic lupus erythematosus: a pilot study
by: L. V. Kondratyeva, et al.
Published: (2020-03-01)

PO.2.43 The activity and damage index in systemic lupus erythematosus depending on antiphospholipid antibodies
by: T Reshetnyak, et al.
Published: (2022-10-01)

LP-019 Social maladjustment and anxiety-depressive spectrum disorders in system lupus erythematosus and primary antiphospholipid syndrome patients
by: Tatiana Reshetnyak, et al.
Published: (2023-07-01)

P15 Oxidative stress in incomplete systemic lupus erythematosus patients compared to systemic lupus erythematosus and healthy controls
by: Lu Liu, et al.
Published: (2024-03-01)

LP-066 Severe Systemic lupus erythematosus with manifestation of lupus nephritis and pericardial effusion: a case report
by: Arief Nurudhin, et al.
Published: (2023-07-01)

LP-189 Effect of belimumab in patients with systemic lupus erythematosus treated with minimal or no steroid
by: Ji Seon Oh, et al.
Published: (2023-07-01)

LP-154 Peripheral gangrene in systemic lupus erythematosus – a rare case report
by: Faridin Pango, et al.
Published: (2023-07-01)

LP-175 Frequencies, clinical characteristics and prognosis of patients with neuropsychiatric systemic lupus erythematosus
by: Chak Sing Lau, et al.
Published: (2023-07-01)

LP-197 Association between steroid therapy and IGRA Result in systemic lupus erythematosus
by: Laniyati Hamijoyo, et al.
Published: (2023-07-01)

LP-073 Identification of systemic lupus erythematosus classification criteria attributes in a regional medical record data network
by: Rosalind Ramsey-Goldman, et al.
Published: (2023-07-01)

Systemic lupus erythematosus: new horizons for diagnosis and therapy
by: S. K. Solovyev, et al.
Published: (2020-02-01)